This page contains a Flash digital edition of a book.
Endovascular


1. Jean WJ, al-Bittar I, Zwicke DL, et al., High incidence of renal artery stenosis in patients with coronary artery disease, Catheter Cardiovasc Diagn, 1994;32(1):8–10.


2. Uzu T, Inoue T, Fuji T, et al., Prevalence and predictors of renal artery stenosis in patients with myocardial infarction, Am J Kidney Dis, 1997;29(5):733–8.


3. Kuroda S, Nishida N, Uzu T, et al., Prevalence of renal artery stenosis in autopsy patients with stroke, Stroke, 2000;31(1):61–5.


4. Miralles M, Corominas A, Cotillas J, et al., Screening for carotid and renal artery stenoses in patients with aortoiliac disease, Ann Vasc Surg, 1998;12(1):17–21.


5. Valentine RJ, Myers SI, Miller GL, et al., Detection of unsuspected renal artery stenoses in patients with abdominal aortic aneurysms: refined indications for preoperative aortography, Ann Vasc Surg, 1993;7(3):220–4.


6. Olin JW, Melia M, Young JR, et al., Prevalence of renal artery stenosis in patients with atherosclerosis elsewhere, Am J Med, 1990;88(1N):46N–51N.


7. Zierler RE, Bergelin RO, Polissar NL, et al., Carotid and lower extremity disease in patients with renal artery atherosclerosis, Arch Intern Med, 1998;158(7):761–7.


8. Goldblatt H, Lynch J, Hanzal RF, Summerville WW, Studies on experimental hypertension: production of persistent elevation of systolic blood pressure by means of renal ischemia, J Exp Med, 1934;59(3):347–79.


9. Wollenweber J, Sheps SG, Davis GD, Clinical course of atherosclerotic renovascular disease, Am J Cardiol, 1968;21(1):60–71.


10. Sheps SG, Osmundson PJ, Hunt JC, et al., Hypertension and renal artery stenosis: serial observations on 54 patients treated medically, Clin Pharm Ther, 1965;6:700–9.


11. Valentien RJ, Claggett GP, Miller GL, et al., The coronary risk of unsuspected renal artery stenosis, J Vasc Surg, 1993;18(3):433–9.


12. Conlon PJ, Athirakul K, Kovalik E, et al., Survival in renal vascular disease, J Am Soc Nephrol, 1998;9(2):252–6.


13. Baboolal K, Evans C and Moore RH, Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renal vascular disease, Am J Kidney Dis, 1998;31(6):971–7.


14. Wright JR, Shurrab AE, Cheung C, et al., A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renal vascular disease, Am J Kidney Dis, 2002;39(6):1153–61.


15. Mailloux LU, Napolitno B, Bellucci AG, et al., Renal vascular disease causing end-stage renal disease, incidence, clinical correlates and outcomes: A 20-year clinical experience, Am J Kidney Dis, 1994;24(4):622–9.


16. Johansson M, Herlitz H, Jensen G, et al., Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal


function and treatment regimens, J Hypertens, 1999;17(12):1743–50.


17. Kalra PA, Guo H, Kausz AT, et al., Atherosclerotic renal vascular disease in United State patients aged 67 years and older: risk factors, revascularization, and prognosis, Kidney Int, 2005;68(1):293–301.


18. Cambria RP, Brewster DC, L’Italien GJ, et al., The durability of different reconstructive techniques for atherosclerotic renal artery disease, J Vasc Surg, 1994;20(1):76–87.


19. Gruntzig A, Kuhlmann U, Vetter W, et al., Treatment of renal artery stenosis with percutaneous transluminal dilatation of a renal-artery stenosis, Lancet 1978;1(8068):801–2.


20. Mahler F, Krneta A, Haertel M, Treatment of renovascular hypertension by transluminal renal artery dilatation, Ann Intern Med, 1979;90(1):56–7.


21. Dorros G, Prince C, Mathiak L, Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty alone, Cathet Cardiovasc Diagn, 1993;29(3):191–8.


22. Modrall JG, Rosero EB, Smith ST, et al., Operative mortality for renal artery bypass in the United States: results from the National Inpatient Sample, J Vasc Surg, 2008;48(2):317–22.


23. Bergqvist D, Björck M, Lundgren F, Troëng T, Invasive treatment for renovascular disease. A twenty year experience from a population based registry, J Cardiovasc Surg, 2008;49(5):559–63.


24. Iannone LA, Underwood PL, Nath A, et al., Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis, Cathet Cardiovasc Diagn, 1996;37(3):243–50.


25. Harden PN, MacLeod MJ, Rodger RSC, et al., Effect of renal- artery stenting on progression of renovascular renal failure, Lancet, 1997;349(9059):1133–6.


26. Giroux MF, Soulez G, Thérasse E, et al., Percutaneous revascularization of the renal arteries: Predictors of outcome, J Vasc Interv Radiol, 2000;11(6):713–20.


27. Burket MW, Cooper CJ, Kennedy DJ, et al., Renal artery angioplasty and stent placement: predictors of a favorable outcome, Am Heart J, 2000;139(1):64–71.


28. Dorros G, Jaff M, Mathiak L, et al., Multicenter Palmaz stent renal artery stenosis revascularization registry report: four- year follow-up of 1,058 successful patients, Cathet Cardiovasc Interv, 2002;55(2):182–8.


29. Kennedy DJ, Colyer WR, Brewster PS, et al., Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement, Am J Kidney Dis, 2003;42(5):926–35.


30. Cooper CJ, Haller ST, Colyer W, et al., Embolic protection and platelet inhibition during renal artery stenting, Circulation, 2008;117(21):2752–60.


31. Kanjwal K, Cooper CJ, Virmani R, et al., Predictors of


embolization during protected renal artery angioplasty and stenting: role of antiplatelet therapy, Cathet Cardiovasc Intervent, 2010;76(1):16–23.


32. Laird JR, Rundback J, Zierler E, et al., Safety and efficacy of renal artery stenting following suboptimal renal angioplasty for de novo and restenostic ostial lesions: results from a nonrandomized, prospective multicenter registry, J Vasc Interv Radiol, 2010;21(5):627–37.


33. Sapoval M, Tamari I, Goffette P, et al., One year outcomes of renal artery stenting: the results of the ODORI registry, Cardiovasc Intervent Radiol, 2010;33(3):475–83.


34. Kalra PA, Chrysochou C, Green D, et al., The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease, Cathet Cardiovasc Intervent, 2010;75(1):1–10.


35. Yu H, Zhang D, Kanjwal K, et al., Severity of renal artery stenosis predicts baseline and residual renal function in patients undergoing renal artery stenting, Circulation, 2010;122:A19757.


36. Plouin PF, Chatellier G, Darné B, Raynaud A, Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs. Angioplastie (EMMA) Study Group, Hypertension, 1998;31(3):823–9


37. Webster J, Marshall F, Abdalla M, et al., Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and New Castle Renal Artery Stenosis Collaborative Group, J Hum Hypertens, 1998;12(5):329–35.


38. van Jaarsveld BC, Krijinen P, Pieterman H, et al., The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group, N Engl J Med, 2000;342(14):1007–14.


39. Bax L, Woittiez AJJ, Kouwenberg HJ, et al., Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial, Ann Intern Med, 2009;150(12):840–8.


40. ASTRAL Investigators, Wheatley K, Ives N, et al., Revascularization versus medical therapy for renal artery stenosis, N Engl J Med, 2009;361(20):1953–62.


41. Cooper CJ, Murphy TP, Matsumoto A, et al., Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial, Am Heart J, 2006;152(1):59–66.


42. Schwarzwalder U, Hauk M, Zeller T, RADAR – A randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis, Trials, 2009;10:60.


92


INTERVENTIONAL CARDIOLOGY


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100